دورية أكاديمية
Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
| العنوان: | Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study |
|---|---|
| المؤلفون: | Akiyama, Eiichi, Cinotti, Raphaël, Čerlinskaitė, Kamilė, van Aelst, Lucas, N L, Arrigo, Mattia, Placido, Rui, Chouihed, Tahar, Girerd, Nicolas, Zannad, Faiez, Rossignol, Patrick, Badoz, Marc, Launay, Jean-Marie, Gayat, Etienne, Cohen-Solal, Alain, Lam, Carolyn, S P, Testani, Jeffrey, Mullens, Wilfried, Cotter, Gad, Seronde, Marie-France, Mebazaa, Alexandre |
| المساهمون: | Division of Cardiology, Yokohama City University Medical Center, Marqueurs cardiovasculaires en situation de stress (MASCOT (UMR_S_942 / U942)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Service de cardiologie (APHP-Hôpital Lariboisière), Hôpital Lariboisière-APHP, University hospital of Zurich Zurich, Département d’Anesthésie-Réanimation-SMUR Hôpital Lariboisière, Hôpitaux Universitaire Saint-Louis, Lariboisière, Fernand-Widal, Hospital de Santa Maria Lisboa, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), UFR de Médicine, Sorbonne Paris Cité, Paris Diderot University, Paris, Service d’Accueil des urgences CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Department of Cardiology, University Hospital Jean Minjoz, Department of Medical Biochemistry and Molecular Biology, Hôpital Lariboisière, Center for Biological Resources BB-033-00064, Hôpital Lariboisière, Université Sorbonne Paris Cité (USPC), Department of Cardiology, Hôpitaux Universitaires Saint Louis-Lariboisière, Assistance Publique des Hopitaux de Paris, National Heart Centre Singapore (NHCS), Duke-National University of Singapore Graduate Medical School, University Medical Center Groningen Groningen (UMCG), Yale School of Medicine New Haven, Connecticut (YSM), Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Hasselt University (UHasselt), Momentum Research Inc., Durham, Department of Anesthesiology and Critical Care, Hôpitaux Universitaires Saint Louis-Lariboisiere, Assistance Publique des Hopitaux de Paris, This study was supported by a grant from the European Union funded by the Seventh Framework Programme for Health in 2010 (FP7-HEALTH-2010-MEDIA, Luxembourg) (F.Z., P.R., A. M) and research fellowship from Japan Heart Foundation (E. A.). P.R., N.G., T.C., and F.Z. are supported by a public grant overseen by the French National Research Agency (ANR) as part of the second “Investissements d’Avenir” programmes Fighting Heart Failure (reference: ANR-15-RHU-0004), GEENAGE Impact Lorraine Université d’Excellence and by the Contrat de Plan Etat Région Lorraine IT2MP and FEDER Lorraine., IMPACT GEENAGE, ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), European Project: 261409,EC:FP7:HEALTH,FP7-HEALTH-2010-single-stage,MEDIA(2011) |
| المصدر: | EISSN: 2055-5822 ; ESC Heart Failure ; https://hal.univ-lorraine.fr/hal-02885307Test ; ESC Heart Failure, 2020, 7 (3), pp.996-1006. ⟨10.1002/ehf2.12645⟩ |
| بيانات النشر: | HAL CCSD Wiley |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Acute heart failure, Heart fail- ure with reduced ejection fraction, Echocardiography, Heart failure with reduced ejection fraction, Congestion, Biomarker, Heart failure with preserved ejection fraction, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system |
| الوصف: | International audience ; Aims: Changes in echocardiographic parameters and biomarkers of cardiac and venous pressures or estimated plasma volume during hospitalization associated with decongestive treatments in acute heart failure (AHF) patients with either preserved left ventricular ejection fraction (LVEF) (HFPEF) or reduced LVEF (HFREF) are poorly assessed.Methods and results: From the metabolic road to diastolic heart failure: diastolic heart failure (MEDIA-DHF) study, 111 patients were included in this substudy: 77 AHF (43 HFPEF and 34 HFREF) and 34 non-cardiac dyspnea patients. Echocardiographic measurements and blood samples were obtained within 4 h of presentation at the emergency department and before hospital discharge. In AHF patients, echocardiographic indices of cardiac and venous pressures, including inferior vena cava diameter [from 22 (16-24) mm to 13 (11-18) mm, P = 0.009], its respiratory variability [from 32 (8-44) % to 43 (29-70) %, P = 0.04], medial E/e' [from 21.1 (15.8-29.6) to 16.6 (11.7-24.3), P = 0.004], and E wave deceleration time [from 129 (105-156) ms to 166 (128-203) ms, P = 0.003], improved during hospitalization, similarly in HFPEF and HFREF patients. By contrast, no changes were seen in non-cardiac dyspnea patients. In AHF patients, all plasma biomarkers of cardiac and venous pressures, namely B-type natriuretic peptide [from 935 (514-2037) pg/mL to 308 (183-609) pg/mL, P < 0.001], mid-regional pro-atrial natriuretic peptide [from 449 (274-653) pmol/L to 366 (242-549) pmol/L, P < 0.001], and soluble CD-146 levels [from 528 (406-654) ng/mL to 450 (374-529) ng/mL, P = 0.003], significantly decreased during hospitalization, similarly in HFPEF and HFREF patients. Echocardiographic parameters of cardiac chamber dimensions [left ventricular end-diastolic volume: from 120 (76-140) mL to 118 (95-176) mL, P = 0.23] and cardiac index [from 2.1 (1.6-2.6) mL/min/m2 to 1.9 (1.4-2.4) mL/min/m2 , P = 0.55] were unchanged in AHF patients, except tricuspid annular plane systolic excursion ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/32277607; info:eu-repo/grantAgreement/EC/FP7/261409/EU/The MEtabolic Road to DIAstolic Heart Failure/MEDIA; hal-02885307; https://hal.univ-lorraine.fr/hal-02885307Test; https://hal.univ-lorraine.fr/hal-02885307/documentTest; https://hal.univ-lorraine.fr/hal-02885307/file/ehf2.12645.pdfTest; PUBMED: 32277607; PUBMEDCENTRAL: PMC7261539 |
| DOI: | 10.1002/ehf2.12645 |
| الإتاحة: | https://doi.org/10.1002/ehf2.12645Test https://hal.univ-lorraine.fr/hal-02885307Test https://hal.univ-lorraine.fr/hal-02885307/documentTest https://hal.univ-lorraine.fr/hal-02885307/file/ehf2.12645.pdfTest |
| حقوق: | http://creativecommons.org/licenses/by-ncTest/ ; info:eu-repo/semantics/OpenAccess |
| رقم الانضمام: | edsbas.E504F150 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1002/ehf2.12645 |
|---|